Indian pharma company begins human trials for COVID-19 vaccine
The first dosage of its plasmid DNA vaccine ZyCoV-D was administered to a human test subject on Wednesday.
ADVERTISEMENT
The first dosage of its plasmid DNA vaccine ZyCoV-D was administered to a human test subject on Wednesday.